Invivyd

About Invivyd

Invivyd is a commercial-stage biopharmaceutical company pioneering antibody-based therapies for serious viral infectious diseases. You will help us protect vulnerable patients from constantly evolving viral threats, starting with SARS-CoV-2. Our INVYMAB Platform combines viral surveillance, predictive modeling, and advanced antibody engineering. This platform allows us to rapidly develop and adapt new monoclonal antibody candidates. We have already brought one antibody therapy, PEMGARDA, to market with U.S. FDA emergency use authorization. We are advancing new programs like VYD2311 through Phase 3 clinical trials, building a robust pipeline of solutions. Join a team backed by $466 million in funding, dedicated to making a tangible impact on global health.

How We Work

You will work in a culture that embraces change and promotes nimble decision-making. We relentlessly pursue our mission to protect vulnerable populations. We are a remote-first organization with job postings specifying regional remote locations. This structure allows us to access top talent and foster a focused, results-driven environment.

Why Join Us

• Make a real difference for immunocompromised patients facing viral threats.
• Work on innovative antibody-based therapies from discovery to commercialization.
• Contribute to an authorized FDA product and a robust pipeline including Phase 3 candidates.
• Receive annual short-term incentives and long-term equity to reward your impact.
• Collaborate in a culture that values adaptability, compliance, and ethical conduct.

Benefits & Perks

• Annual short-term incentive (bonus or sales incentive)
• Annual long-term incentive (equity)
• Stock options vesting over four years (25% on first anniversary, then monthly)